LIGAND PHARMACEUTICALS INCORPORATED Retained Earnings
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Retained Earnings of $583.25 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07
- 2026-06-30: Retained Earnings (Accumulated Deficit) $583.25M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $594.74M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $608.09M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) $578.22M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | $583.25M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $594.74M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $608.09M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $578.22M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $461.38M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $456.53M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $498.98M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $530.07M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $537.24M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $589.15M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $503.02M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $484.83M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $495.10M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $492.81M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $450.86M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $468.35M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $467.94M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $468.84M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $449.09M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $454.51M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $440.78M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $410.06M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $391.95M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $386.19M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $392.89M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $370.81M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $400.11M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $407.47M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $422.72M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $437.14M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$229.20M 10-K · filed 2020-02-27 | |
| 2018-09-30 | -$183.91M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$254.24M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$327.40M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$400.92M 10-K · filed 2019-02-28 | |
| 2017-09-30 | -$393.91M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$402.34M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$408.40M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$431.13M 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$428.00M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$429.05M 10-Q · filed 2016-11-14 | -$401.17M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$422.88M 10-Q · filed 2016-11-14 | -$395.40M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$429.49M 10-K · filed 2017-02-28 | -$402.01M 10-K · filed 2016-02-26 |
| 2015-09-30 | -$435.83M 10-Q · filed 2016-11-14 | -$410.46M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$635.00M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$658.56M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$659.32M 10-K · filed 2016-11-14 | -$671.34M 10-K · filed 2014-12-01 |
| 2014-09-30 | -$666.37M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | -$667.65M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | -$669.24M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | -$671.34M 10-K · filed 2015-02-23 | |
| 2013-09-30 | -$673.21M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$675.17M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | -$681.26M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | -$682.76M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | -$683.82M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$683.63M 10-Q/A · filed 2012-11-14 | -$682.65M 10-Q · filed 2012-08-08 |
| 2012-03-31 | -$681.10M 10-Q/A · filed 2012-11-14 | -$680.39M 10-Q · filed 2012-05-04 |
| 2011-12-31 | -$682.23M 10-K · filed 2013-03-14 | -$681.77M 10-K · filed 2012-02-23 |
| 2011-09-30 | -$686.58M 10-Q/A · filed 2012-02-10 | -$687.27M 10-Q · filed 2011-11-08 |
| 2011-06-30 | -$682.84M 10-Q/A · filed 2012-02-10 | -$683.38M 10-Q · filed 2011-08-08 |
| 2010-12-31 | -$691.95M 10-K/A · filed 2012-11-14 |